ENOCHIAN BIOSCIENCES INC (RENB)
Institutional ownership reported to the SEC as of Q1 2026, across 30 quarters.
1
Reporting holders
$258
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Fortitude Family Office, LLC | $258 | 632 | 0.00% | 2q | +33.6% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 1 | $258 | 632 | 0 | 1 | 0 | 0.0% |
| Q4 2025 | 1 | $417 | 473 | 1 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $7 | 5 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 40 | $4.2M | 14,300,543 | 13 | 8 | 16 | 0.7% |
| Q1 2025 | 55 | $11.9M | 21,835,285 | 8 | 16 | 17 | 0.6% |
| Q4 2024 | 53 | $18.4M | 21,924,261 | 10 | 29 | 6 | 0.4% |
| Q3 2024 | 45 | $7.1M | 14,717,398 | 14 | 13 | 7 | 0.3% |
| Q2 2024 | 35 | $24.7M | 14,069,471 | 13 | 10 | 9 | 0.2% |
| Q1 2024 | 36 | $21.1M | 7,936,325 | 12 | 14 | 5 | 0.4% |
| Q4 2023 | 31 | $9.3M | 2,903,906 | 10 | 15 | 3 | 0.8% |
| Q3 2023 | 20 | $6.9M | 1,488,192 | 3 | 8 | 4 | 3.3% |
| Q2 2023 | 30 | $934.4K | 1,637,200 | 5 | 4 | 19 | 0.7% |
| Q1 2023 | 34 | $2.8M | 3,066,888 | 5 | 12 | 8 | 0.0% |
| Q4 2022 | 30 | $3.1M | 3,011,094 | 5 | 5 | 9 | 1.3% |
| Q3 2022 | 39 | $6.9M | 3,789,064 | 5 | 14 | 11 | 1.0% |
| Q2 2022 | 48 | $8.3M | 3,957,370 | 23 | 16 | 8 | 7.9% |
| Q1 2022 | 42 | $21.6M | 2,604,864 | 8 | 15 | 12 | 0.4% |
| Q4 2021 | 44 | $18.2M | 2,471,225 | 18 | 10 | 5 | 1.2% |
| Q3 2021 | 31 | $10.5M | 1,519,012 | 9 | 7 | 11 | 2.7% |
| Q2 2021 | 32 | $13.3M | 2,668,928 | 9 | 3 | 18 | 0.0% |
| Q1 2021 | 41 | $9.6M | 2,713,109 | 5 | 15 | 10 | 0.0% |
| Q4 2020 | 40 | $7.2M | 2,446,540 | 6 | 12 | 12 | 0.0% |
| Q3 2020 | 38 | $8.5M | 2,381,680 | 7 | 8 | 11 | 0.0% |
| Q2 2020 | 33 | $10.4M | 2,469,686 | 4 | 12 | 7 | 0.0% |
| Q1 2020 | 32 | $6.9M | 2,286,724 | 2 | 12 | 9 | 0.0% |
| Q4 2019 | 33 | $11.9M | 2,365,129 | 8 | 18 | 1 | 0.0% |
| Q3 2019 | 29 | $6.4M | 1,168,685 | 4 | 9 | 10 | 0.0% |
| Q2 2019 | 29 | $5.5M | 1,235,206 | 16 | 6 | 5 | 0.0% |
| Q1 2019 | 17 | $6.3M | 902,545 | 16 | 0 | 0 | 0.0% |
| Q4 2018 | 2 | $21.0K | 2,941 | 0 | 0 | 0 | 0.0% |